AI IntelligenceJun 18, 2026Primary Market
Article
bioAffinity Technologies, Inc. · Not disclosed · Unbekannt
bioAffinity Technologies has entered into a material definitive agreement, indicating a potential financing or partnership. The company develops non-invasive diagnostics for cancer.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
bioAffinity Technologies has entered into a material definitive agreement, indicating a potential financing or partnership. The company develops non-invasive diagnostics for cancer.